Brief: Apontis Pharma Announces Market Launch Of New Single Pill
Oct 26 (Reuters) - APONTIS PHARMA AG APPHG.DE :
* ANNOUNCES MARKET LAUNCH OF NEW SINGLE PILL
* DOUBLING OF ADDRESSABLE PATIENT GROUP EXPECTED BY END OF
2024
* MARKET LAUNCH FOR NEW SINGLE PILL IN GERMANY PLANNED FOR
Q2 2022
Source text for Eikon: ID:nEQ7FJFxfa
Further company coverage: APPHG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Apontis Pharma AG
See all newsBrief: Bruno Wohschlegel To Leave Apontis Pharma As CEO End Of August
Brief: APONTIS PHARMA Q1 EBITDA EUR 1.3 Million
Brief: Apontis Pharma Says Zentiva AG Submits Formal Request To Carry Out A Merger
Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share